Katabi Maha 4
4 · Aerovate Therapeutics, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Katabi Maha
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-06-05+12,500→ 12,500 totalExercise: $18.90Exp: 2034-06-04→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest and become exercisable in full on the earlier of (i) June 5, 2025 or (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service through the applicable vesting date.